Castleark Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,800
Closed -$69K 369
2016
Q4
$69K Hold
1,800
﹤0.01% 364
2016
Q3
$76K Hold
1,800
﹤0.01% 364
2016
Q2
$71K Hold
1,800
﹤0.01% 364
2016
Q1
$75K Hold
1,800
﹤0.01% 356
2015
Q4
$81K Hold
1,800
﹤0.01% 376
2015
Q3
$72K Hold
1,800
﹤0.01% 357
2015
Q2
$88K Hold
1,800
﹤0.01% 362
2015
Q1
$83K Hold
1,800
﹤0.01% 348
2014
Q4
$81K Sell
1,800
-40,000
-96% -$1.74M ﹤0.01% 334
2014
Q3
$1.61M Buy
41,800
+40,000
+2,222% +$1.69M 0.05% 227
2014
Q2
$74K Sell
1,800
-40,000
-96% -$1.57M ﹤0.01% 314
2014
Q1
$1.61M Sell
41,800
-15,100
-27% -$582K 0.05% 227
2013
Q4
$2.18M Buy
56,900
+55,100
+3,061% +$2.03M 0.06% 210
2013
Q3
$75K Sell
1,800
-44,700
-96% -$1.57M ﹤0.01% 338
2013
Q2
$2.27M Buy
+46,500
New +$1.71M 0.08% 184

Other funds holding ABT

Castleark Management's ABT Position: Q1 2017 in Review

Castleark Management sold out of Abbott (ABT) in Q1 2017, closing a stake of 1,800 shares — an estimated $69K sold.

Castleark Management first reported a position in ABT in Q2 2013 and held it in 15 quarters. The position peaked at $2.27M in Q2 2013. 1,590 funds tracked by Wall St. Rank hold ABT as of Q1 2017.

  • Castleark Management reported no remaining Abbott position as of Q1 2017 after selling out during the quarter.
  • Castleark Management sold 1,800 Abbott shares in Q1 2017, an estimated $69K.
  • Castleark Management first reported a position in Abbott in Q2 2013 and held it in 15 quarters.
  • Castleark Management's Abbott position peaked at $2.27M in Q2 2013.
  • 1,590 funds tracked by Wall St. Rank held Abbott as of Q1 2017.

Based on Castleark Management's 13F filing for Q1 2017, filed 15 May 2017.